IP Verse

Use Of Isoxazoline Compounds For Treating Demodicosis

Patent No. EP3236960 (titled "Use Of Isoxazoline Compounds For Treating Demodicosis") was filed by Intervet on Dec 21, 2015. The application was issued on Jan 29, 2025.

Patent Summary

Treatment of generalized demodicosis in dogs using a single oral dose of the isoxazoline compound fluralaner, which achieves complete mite clearance and resolves skin lesions without the need for repeated treatments or topical applications.

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
CEVA SANTE ANIMALEOct 28, 2025CABINET BECKER ET ASSOCIES
VIRBACOct 3, 2025GEVERS & ORES

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3236960

INTERVET
Application Number
EP15817303A
Filing Date
Dec 21, 2015
Status
Granted And Under Opposition
Dec 26, 2024
Publication Date
Jan 29, 2025
External Links
Slate, Register , Google Patents